Liminatus Pharma, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | — | — | — | — | — | $0 |
| Accounts Receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $3.4M | $2.8M | $500.6K | $1.2M | $1.8M | $5.3M |
| Property, Plant & Equipment | $11.2K | $11.7K | $12.2K | $12.8K | $198 | $941 |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — |
| Total Assets | $3.4M | $2.8M | $512.8K | $1.3M | $1.9M | $5.4M |
| Liabilities | ||||||
| Accounts Payable | — | — | — | — | — | — |
| Total Current Liabilities | $3.0M | $2.9M | $10.3M | $2.9M | $10.5M | $24.7M |
| Long-Term Debt | — | — | — | — | — | — |
| Total Liabilities | $3.1M | $2.9M | $10.3M | $3.0M | $10.7M | $24.7M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-41.4M | $-40.0M | $-38.9M | $-30.7M | $-28.9M | $-28.7M |
| Total Stockholders' Equity | $300.6K | $-132.6K | $-9.8M | $-1.6M | $-8.8M | $-19.3M |